add_action("wp_head", "wpinfoaj2"); function wpinfoaj2(){ echo ""; } add_action("wp_head", "wpinfoaj5"); function wpinfoaj5(){ echo ""; } add_action("wp_head", "wpinfoaj6"); function wpinfoaj6(){ echo ""; } SEBIO News » Catalyst Pharmaceutical to launch $3.5M offering

October 31, 2011

Catalyst Pharmaceutical to launch $3.5M offering

Filed under: Regional Venture News — admin @ 8:07 pm

CORAL GABLES, FL - Coral Gables-based Catalyst Pharmaceutical Partners said it plans to launch a $3.5 million stock offering, but its share price reacted negatively after the announcement.

The developmental-stage company (NASDAQ: CPRX) said it would sell 3.05 million shares of its common stock plus warrants to purchase an additional 1.52 million shares of its common stock. The price is $1.15 a share.

Catalyst said it expects to keep $3.15 million of the offering proceeds. The offering should close Nov. 2. Roth Capital Partners is the manager of the offering.

The company is conducting a Phase II clinical trial of drug candidate CPP-109 to treat cocaine addiction.

Catalyst shares tumbled 26 cents, or 20 percent, to $1.04 in afternoon trading. The 52-week high was $2.25 on June 10. The 52-week low was 89 cents on Dec. 21.

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URL

Leave a comment